Information: Detta är inte den senaste versionen av datamodellen. Du hittar en versionsöversikt till vänster under versioner. Den senaste versionen hittar du här.
Information:
Fel:
ID
34332
Beskrivning
Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC); ODM derived from: https://clinicaltrials.gov/show/NCT01392131
Länk
https://clinicaltrials.gov/show/NCT01392131
Nyckelord
Versioner (2)
- 2019-01-16 2019-01-16 -
- 2019-05-14 2019-05-14 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
16 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hepatocellular Carcinoma NCT01392131
Eligibility Hepatocellular Carcinoma NCT01392131
- StudyEvent: Eligibility
Similar models
Eligibility Hepatocellular Carcinoma NCT01392131
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
patients with hcc irrespective of etiology, age, gender and status of underlying liver disease.
boolean
ID.2
Item
patients with hcc who are not suitable candidates for established modalities of treatment i.e. surgery and/or chemotherapy.
boolean
ID.3
Item
patients with hcc who have evidence of tumor metastasis
boolean
ID.4
Item
patients with hcc who are voluntarily unwilling to take established modalities of treatment i.e. surgery and/or chemotherapy.
boolean
ID.5
Item
patients with hcc in whom all possible treatment options have been exhausted.
boolean
ID.6
Item
patients with hcc who are suitable candidates for established modalities of treatment i.e. surgery and/or chemotherapy.
boolean
ID.7
Item
patients with hcc who have no evidence of tumor metastasis
boolean
ID.8
Item
patients with hcc who are willing to take established modalities of treatment i.e. surgery and/or chemotherapy.
boolean
ID.9
Item
patients with hcc who are voluntarily unwilling to be included in the trial
boolean